Steven Simonson - Net Worth and Insider Trading

Steven Simonson Net Worth

The estimated net worth of Steven Simonson is at least $57 dollars as of 2024-05-12. Steven Simonson is the SVP, Chief Medical Officer of Windtree Therapeutics Inc and owns about 14 shares of Windtree Therapeutics Inc (WINT) stock worth over $57. Details can be seen in Steven Simonson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven Simonson has not made any transactions after 2021-03-25 and currently still holds the listed stock(s).

Transaction Summary of Steven Simonson

To

Steven Simonson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Simonson owns 1 companies in total, including Windtree Therapeutics Inc (WINT) .

Click here to see the complete history of Steven Simonson’s form 4 insider trades.

Insider Ownership Summary of Steven Simonson

Ticker Comapny Transaction Date Type of Owner
WINT Windtree Therapeutics Inc 2021-03-25 SVP & Chief Development Officer

Steven Simonson Latest Holdings Summary

Steven Simonson currently owns a total of 1 stock. Steven Simonson owns 14 shares of Windtree Therapeutics Inc (WINT) as of March 25, 2021, with a value of $57.

Latest Holdings of Steven Simonson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
WINT Windtree Therapeutics Inc 2021-03-25 14 4.10 57

Holding Weightings of Steven Simonson


Steven Simonson Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Simonson has made a total of 2 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 2 shares on March 25, 2021, which cost Steven Simonson around $4,875.

Insider Trading History of Steven Simonson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Simonson Trading Performance

GuruFocus tracks the stock performance after each of Steven Simonson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Simonson is 3.53%. GuruFocus also compares Steven Simonson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Simonson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven Simonson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven Simonson

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.74
Relative Return to S&P 500(%) -12.95

Steven Simonson Ownership Network

Ownership Network List of Steven Simonson

No Data

Ownership Network Relation of Steven Simonson


Steven Simonson Owned Company Details

What does Windtree Therapeutics Inc do?

Who are the key executives at Windtree Therapeutics Inc?

Steven Simonson is the SVP & Chief Development Officer of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and SVP & CFO John P. Hamill .

Windtree Therapeutics Inc (WINT) Insider Trades Summary

Over the past 18 months, Steven Simonson made no insider transaction in Windtree Therapeutics Inc (WINT). Other recent insider transactions involving Windtree Therapeutics Inc (WINT) include a net purchase of 7,812 shares made by Craig Fraser ,

In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 434 shares were bought by its insiders, resulting in a net purchase of 434 shares.

Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Windtree Therapeutics Inc Insider Transactions

No Available Data

Steven Simonson Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Simonson. You might contact Steven Simonson via mailing address: 2600 Kelly Road, Suite 100, Warrington Pa 18976.

Discussions on Steven Simonson

No discussions yet.